​

Olema Pharmaceuticals Ownership | Who Owns Olema Pharmaceuticals?

OverviewForecastFinancialsChart

Olema Pharmaceuticals Ownership Summary

Olema Pharmaceuticals is owned by 116.00% institutional investors, 1.80% insiders. Fmr is the largest institutional shareholder, holding 11.94% of OLMA shares. State Street® SPDR® S&P® Biotech ETF is the top mutual fund, with 3.12% of its assets in Olema Pharmaceuticals shares.

OLMA Ownership Benchmark

TypeName% Inst% Insiders% Retail
StockOlema Pharmaceuticals116.00%1.80%-17.79%
SectorHealthcare Stocks 35.58%11.87%52.55%
IndustryBiotech Stocks 35.75%11.83%52.41%

Institutional Shareholders

Top Institutional Shareholders by Total Shares

HolderShares% HoldingValue
Fmr10.39M11.94%$154.87M
Paradigm biocapital advisors lp8.02M9.22%$119.59M
Bain capital life sciences investors7.47M8.59%$111.43M
Janus henderson group7.11M8.17%$106.01M
Blackrock4.00M7.11%$43.27M
Blackrock funding, inc. /de5.65M6.50%$84.27M
Bvf inc/il5.30M6.09%$78.96M
Siren4.76M5.47%$70.93M
State street3.94M4.53%$58.71M
Cormorant asset management, lp3.90M4.48%$58.15M

Top Institutional Shareholders by % of Total Assets

HolderShares% AssetsValue
Bain capital life sciences investors7.47M10.05%$111.43M
Cormorant asset management, lp3.90M2.92%$58.15M
Bvf inc/il5.30M2.52%$78.96M
Paradigm biocapital advisors lp8.02M2.44%$119.59M
Logos global management lp3.21M2.39%$47.84M
Lightspeed management1.36M2.05%$20.21M
Siren4.76M1.97%$70.93M
Ghost tree capital550.00K1.86%$5.95M
Birchview capital, lp219.00K1.86%$3.27M
Kingdon capital management855.00K1.40%$12.75M

Top Buyers

HolderShares% AssetsChange
Fmr10.39M0.01%5.36M
State street3.94M0.00%2.05M
Siren4.76M1.97%1.46M
Cormorant asset management, lp3.90M2.92%1.15M
Duquesne family office986.83K0.44%986.83K

Top Sellers

HolderShares% AssetsChange
Deep track capital, lp---3.47M
Bioimpact capital---2.38M
Avoro capital advisors---1.65M
Franklin resources1.22M0.00%-1.26M
Vestal point capital, lp428.55K0.18%-1.22M

New Positions

HolderShares% AssetsChangeValue
Duquesne family office986.83K0.44%986.83K$14.71M
Boxer capital650.00K0.37%650.00K$7.03M
Vanguard fiduciary trust358.31K0.00%358.31K$5.34M
Qube research312.81K0.01%312.81K$4.66M
Fisher asset management299.76K0.00%299.76K$4.47M

Sold Out

HolderChange
Swan capital-1.00
Hughes financial services-1.00
Nelson, van denburg & campbell wealth management group-6.00
Abich financial wealth management-10.00
Lindbrook capital-41.00

Institutional Ownership Trends

DateHoldingsChange %SharesChange %OwnershipChange %Increased PositionChange %Decreased PositionChange %
Mar 31, 20262172.36%100,923,01511.23%1151.04%118-19.18%5339.47%
Dec 31, 202574-43.51%17,589,137-74.25%200.32%53-19.70%12-66.67%
Sep 30, 202547-58.77%11,890,120-82.11%130.23%20-71.43%15-37.50%
Jun 30, 2025119-10.53%70,425,7516.89%821.38%735.80%25-43.18%
Mar 31, 202510-93.71%26,757,361-62.46%450.29%5-94.57%4-89.19%

Top Mutual Funds Shareholders

HolderShares% HoldingChange
State Street® SPDR® S&P® Biotech ETF2.72M3.12%-27.25K
Vanguard Total Stock Mkt Idx Inv2.43M2.78%-
Vanguard US Total Market Shares ETF1.49M2.18%-
iShares Russell 2000 ETF1.65M1.89%13.91K
Polar Capital Healthcare Opports Inc1.60M1.84%-
Fidelity Select Health Care1.50M1.72%150.00K
Candriam Global Equities Oncology860.55K1.50%187.55K
Pictet-Biotech P USD931.49K1.36%11.40K
Franklin Small Cap Growth SMA917.80K1.34%917.80K
Franklin Small Cap Growth Adv893.20K1.30%-

Recent Insider Transactions

DateNameRoleActivityValue
Mar 03, 2026Mitchell Shawnte CHIEF LEGAL OFFICERSell$345.15K
Mar 04, 2026Mitchell Shawnte CHIEF LEGAL OFFICERSell$600.60K
Mar 04, 2026Mitchell Shawnte CHIEF LEGAL OFFICERSell$5.75K
Jan 20, 2026Harmon Cyrus-Sell$268.80K
Jan 14, 2026Harmon Cyrus-Sell$101.60K

Insider Transactions Trends

DateBuySell
2026 Q2--
2026 Q1-12
2025 Q4-11
2025 Q3-4
2025 Q2--

OLMA Ownership FAQ

Who Owns Olema Pharmaceuticals?

Olema Pharmaceuticals shareholders are primarily institutional investors at 116.00%, followed by 1.80% insiders and -17.80% retail investors. The average institutional ownership in Olema Pharmaceuticals's industry, Biotech Stocks , is 35.75%, which Olema Pharmaceuticals exceeds.

Who owns the most shares of Olema Pharmaceuticals?

Olema Pharmaceuticals’s largest shareholders are Fmr (10.39M shares, 11.94%), Paradigm biocapital advisors lp (8.02M shares, 9.22%), and Bain capital life sciences investors (7.47M shares, 8.59%). Together, they hold 29.75% of Olema Pharmaceuticals’s total shares outstanding.

Does Blackrock own Olema Pharmaceuticals?

Yes, BlackRock owns 7.11% of Olema Pharmaceuticals, totaling 4M shares as of Jun 2024. This represents 0.00% of BlackRock's total assets, with a market value of 43.27M$. In the last quarter, BlackRock increased its holdings by 782.96K shares, a 24.34% change.

Who is Olema Pharmaceuticals’s biggest shareholder by percentage of total assets invested?

Bain capital life sciences investors is Olema Pharmaceuticals’s biggest shareholder by percentage of total assets invested, with 10.05% of its assets in 7.47M Olema Pharmaceuticals shares, valued at 111.43M$.

Who is the top mutual fund holder of Olema Pharmaceuticals shares?

State Street® SPDR® S&P® Biotech ETF is the top mutual fund holder of Olema Pharmaceuticals shares, with 3.12% of its total shares outstanding invested in 2.72M Olema Pharmaceuticals shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

  • Customize your own personal stocks lists, views and charts

  • Choose from hundreds of fields, up to 15 years of history

  • Conduct deep comparison analysis

  • Discover trending investment themes

  • Find your next best investment

  • Research stocks using tools